Robeco Institutional Asset Management B.V. trimmed its holdings in Dolby Laboratories (NYSE:DLB – Free Report) by 15.2% in the 3rd quarter, HoldingsChannel reports. The fund owned 362,743 shares of the electronics maker’s stock after selling 64,948 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Dolby Laboratories were worth $21,318,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Hsbc Holdings PLC lifted its stake in shares of Dolby Laboratories by 396.1% in the 1st quarter. Hsbc Holdings PLC now owns 31,259 shares of the electronics maker’s stock valued at $1,875,000 after purchasing an additional 24,958 shares during the last quarter. Pacer Advisors Inc. increased its position in shares of Dolby Laboratories by 8.0% during the 1st quarter. Pacer Advisors Inc. now owns 516,292 shares of the electronics maker’s stock worth $31,008,000 after purchasing an additional 38,389 shares during the last quarter. Entropy Technologies LP acquired a new position in Dolby Laboratories in the first quarter valued at about $1,674,000. Wellington Management Group LLP boosted its stake in Dolby Laboratories by 19.4% during the second quarter. Wellington Management Group LLP now owns 320,156 shares of the electronics maker’s stock worth $16,834,000 after buying an additional 52,053 shares during the period. Finally, Public Employees Retirement System of Ohio purchased a new position in Dolby Laboratories during the second quarter worth about $951,000. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Stock Down 0.5%
Shares of NYSE:DLB opened at $62.94 on Friday. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $69.95. The firm’s 50 day moving average price is $60.76 and its 200 day moving average price is $57.64. The stock has a market cap of $5.90 billion, a price-to-earnings ratio of 26.78 and a beta of 0.78.
Dolby Laboratories announced that its Board of Directors has authorized a stock repurchase program on Thursday, July 30th that allows the company to buy back $350.00 million in outstanding shares. This buyback authorization allows the electronics maker to purchase up to 7% of its stock through open market purchases. Share buyback programs are generally a sign that the company’s board believes its stock is undervalued.
Dolby Laboratories Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s payout ratio is 61.28%.
Insider Transactions at Dolby Laboratories
In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of the firm’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the sale, the senior vice president directly owned 166,803 shares in the company, valued at $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $62.71, for a total value of $188,130.00. Following the completion of the sale, the senior vice president owned 73,274 shares in the company, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 28,889 shares of company stock valued at $1,749,388. Insiders own 37.93% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on the stock. Zacks Research cut shares of Dolby Laboratories from a “hold” rating to a “strong sell” rating in a research report on Thursday, October 15th. Weiss Ratings upgraded shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Finally, Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, August 28th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $87.50.
Read Our Latest Stock Analysis on Dolby Laboratories
About Dolby Laboratories
Dolby Laboratories, Inc develops audio and imaging technologies used to enhance entertainment and communications experiences. The company’s technologies are incorporated into cinema, television, broadcast, streaming, mobile, personal computer, automotive and gaming products and services.
Its principal offerings include Dolby Atmos, an object-based audio technology designed to create immersive sound, and Dolby Vision, a high-dynamic-range imaging technology intended to improve picture quality.
Featured Stories
- Five stocks we like better than Dolby Laboratories
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
- Chefs’ Warehouse Has Rallied 76%—Can the Stock Keep Climbing?
- MarketBeat Week in Review – 10/19 – 10/23
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
